» Articles » PMID: 25068654

Activin A Balance Regulates Epithelial Invasiveness and Tumorigenesis

Overview
Journal Lab Invest
Specialty Pathology
Date 2014 Jul 29
PMID 25068654
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Activin A (Act A) is a member of the TGFβ superfamily. Act A and TGFβ have multiple common downstream targets and have been described to merge in their intracellular signaling cascades and function. We have previously demonstrated that coordinated loss of E-cadherin and TGFβ receptor II (TβRII) results in epithelial cell invasion. When grown in three-dimensional organotypic reconstruct cultures, esophageal keratinocytes expressing dominant-negative mutants of E-cadherin and TβRII showed activated Smad2 in the absence of functional TβRII. However, we could show that increased levels of Act A secretion was able to induce Smad2 phosphorylation. Growth factor secretion can activate autocrine and paracrine signaling, which affects crosstalk between the epithelial compartment and the surrounding microenvironment. We show that treatment with the Act A antagonist Follistatin or with a neutralizing Act A antibody can increase cell invasion in organotypic cultures in a fibroblast- and MMP-dependent manner. Similarly, suppression of Act A with shRNA increases cell invasion and tumorigenesis in vivo. Therefore, we conclude that maintaining a delicate balance of Act A expression is critical for homeostasis in the esophageal microenvironment.

Citing Articles

Neutrophil-derived Activin-A moderates their pro-NETotic activity and attenuates collateral tissue damage caused by Influenza A virus infection.

Divolis G, Synolaki E, Doulou A, Gavriil A, Giannouli C, Apostolidou A Front Immunol. 2024; 15:1302489.

PMID: 38476229 PMC: 10929267. DOI: 10.3389/fimmu.2024.1302489.


The Reign of Follistatin in Tumors and Their Microenvironment: Implications for Drug Resistance.

Sosa J, Oyelakin A, Sinha S Biology (Basel). 2024; 13(2).

PMID: 38392348 PMC: 10887188. DOI: 10.3390/biology13020130.


APE1 Upregulates MMP-14 via Redox-Sensitive ARF6-Mediated Recycling to Promote Cell Invasion of Esophageal Adenocarcinoma.

Lu H, Bhat A, Peng D, Chen Z, Zhu S, Hong J Cancer Res. 2019; 79(17):4426-4438.

PMID: 31308045 PMC: 6726537. DOI: 10.1158/0008-5472.CAN-19-0237.


NRF2 antioxidant response protects against acidic bile salts-induced oxidative stress and DNA damage in esophageal cells.

Peng D, Lu H, Zhu S, Zhou Z, Hu T, Chen Z Cancer Lett. 2019; 458:46-55.

PMID: 31132430 PMC: 6571054. DOI: 10.1016/j.canlet.2019.05.031.


Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage.

Zhou Z, Lu H, Zhu S, Gomaa A, Chen Z, Yan J J Exp Clin Cancer Res. 2019; 38(1):13.

PMID: 30626422 PMC: 6327430. DOI: 10.1186/s13046-018-1021-y.


References
1.
Yoshinaga K, Mimori K, Inoue H, Kamohara Y, Yamashita K, Tanaka F . Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line. Int J Oncol. 2008; 33(3):453-9. View

2.
Yoshinaga K, Mimori K, Yamashita K, Utsunomiya T, Inoue H, Mori M . Clinical significance of the expression of activin A in esophageal carcinoma. Int J Oncol. 2002; 22(1):75-80. View

3.
Fuchs E, Horsley V . More than one way to skin . . . Genes Dev. 2008; 22(8):976-85. PMC: 2732395. DOI: 10.1101/gad.1645908. View

4.
Massague J . TGFbeta in Cancer. Cell. 2008; 134(2):215-30. PMC: 3512574. DOI: 10.1016/j.cell.2008.07.001. View

5.
Hempen P, Zhang L, Bansal R, Iacobuzio-Donahue C, Murphy K, Maitra A . Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. Cancer Res. 2003; 63(5):994-9. View